Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 13Thoracic 5Other hematologic neoplasm 5Genitourinary 5Gastrointestinal 5Lymphoid 3Tumor-Agnostic 2Sarcoma 2Head & Neck 2Gynecologic 2CNS 2Plasma cell 1Classical hematology 1

Conditions

Trismus 2Radiation Injuries 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphedema 1Head and Neck Neoplasms 1Fibrosis 1

Interventions

Cisplatin 619pembrolizumab 323Radiotherapy 319Cetuximab 274Docetaxel 220Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 74Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 48Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 43tislelizumab 42Standard of Care 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Physical Therapy Modalities × Head & Neck × Clear all
NCT03178110 2020-07-22

Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer

University of Alberta

Phase NA Completed
10 enrolled
Head & Neck

Head and Neck Neoplasms, Trismus

NCT00780312 2013-07-02

HOHF

Rigshospitalet, Denmark

Phase 2 Completed
97 enrolled
Head & Neck

Fibrosis, Lymphedema, Mouth Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Trismus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡